| Dr Julia A Schaefer-cutillo, MD | |
|
1503b N Road St, Elizabeth City, NC 27909-3243 | |
| (252) 331-2044 | |
| Not Available |
| Full Name | Dr Julia A Schaefer-cutillo |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 21 Years |
| Location | 1503b N Road St, Elizabeth City, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912911389 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Albemarle Home Care And Hospice | Elizabeth city, NC | Home health agency |
| Community Hospice Llc | New bern, NC | Hospice |
| Sentara Albemarle Medical Center | Elizabeth city, NC | Hospital |
| The Outer Banks Hospital, Inc | Nags head, NC | Hospital |
| Sentara Leigh Hospital | Norfolk, VA | Hospital |
| Vidant Chowan Hospital | Edenton, NC | Hospital |
| Chesapeake Regional Medical Center | Chesapeake, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Oncology Associates | 2769395797 | 101 |
| Virginia Oncology Associates | 2769395797 | 101 |
| Coastal Rehabilitation Inc | 9537071535 | 113 |
News Archive
While most frequently associated with women's health, age-related hormone changes, often dubbed menopause, can occur in men as well, causing symptoms of fatigue, mood swings, decreased desire for sex, hair loss, lack of concentration and weight gain. Experts estimate that more than 5 million men are affected, yet worry the number may be considerably higher since symptoms are frequently ignored.
Bayer HealthCare announced today that the New Drug Application for its oral investigational compound riociguat has been accepted for filing and granted priority review by the U.S. Food and Drug Administration for the treatment of inoperable chronic thromboembolic pulmonary hypertension or with persistent or recurrent CTEPH after pulmonary endarterectomy and pulmonary arterial hypertension.
Scientists in Spain have found that adding a can of tuna or other fish to our shopping lists could help protect us against bladder cancer.
Seaside Therapeutics LLC today announced that the Company has initiated a Phase 1 clinical trial of STX107, a highly potent, selective mGluR5 antagonist, in development for the treatment of Fragile X Syndrome. The single ascending dose study is designed to evaluate the safety, tolerability and pharmacokinetics of STX107 in healthy volunteers. Fragile X Syndrome is the most common inherited form of mental impairment and the most common known cause of autism.
› Verified 8 days ago
| Entity Name | Virginia Oncology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417929639 PECOS PAC ID: 2769395797 Enrollment ID: O20050914000803 |
News Archive
While most frequently associated with women's health, age-related hormone changes, often dubbed menopause, can occur in men as well, causing symptoms of fatigue, mood swings, decreased desire for sex, hair loss, lack of concentration and weight gain. Experts estimate that more than 5 million men are affected, yet worry the number may be considerably higher since symptoms are frequently ignored.
Bayer HealthCare announced today that the New Drug Application for its oral investigational compound riociguat has been accepted for filing and granted priority review by the U.S. Food and Drug Administration for the treatment of inoperable chronic thromboembolic pulmonary hypertension or with persistent or recurrent CTEPH after pulmonary endarterectomy and pulmonary arterial hypertension.
Scientists in Spain have found that adding a can of tuna or other fish to our shopping lists could help protect us against bladder cancer.
Seaside Therapeutics LLC today announced that the Company has initiated a Phase 1 clinical trial of STX107, a highly potent, selective mGluR5 antagonist, in development for the treatment of Fragile X Syndrome. The single ascending dose study is designed to evaluate the safety, tolerability and pharmacokinetics of STX107 in healthy volunteers. Fragile X Syndrome is the most common inherited form of mental impairment and the most common known cause of autism.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julia A Schaefer-cutillo, MD 6350 Center Dr Ste 200, Norfolk, VA 23502-4107 Ph: (757) 213-5700 | Dr Julia A Schaefer-cutillo, MD 1503b N Road St, Elizabeth City, NC 27909-3243 Ph: (252) 331-2044 |
News Archive
While most frequently associated with women's health, age-related hormone changes, often dubbed menopause, can occur in men as well, causing symptoms of fatigue, mood swings, decreased desire for sex, hair loss, lack of concentration and weight gain. Experts estimate that more than 5 million men are affected, yet worry the number may be considerably higher since symptoms are frequently ignored.
Bayer HealthCare announced today that the New Drug Application for its oral investigational compound riociguat has been accepted for filing and granted priority review by the U.S. Food and Drug Administration for the treatment of inoperable chronic thromboembolic pulmonary hypertension or with persistent or recurrent CTEPH after pulmonary endarterectomy and pulmonary arterial hypertension.
Scientists in Spain have found that adding a can of tuna or other fish to our shopping lists could help protect us against bladder cancer.
Seaside Therapeutics LLC today announced that the Company has initiated a Phase 1 clinical trial of STX107, a highly potent, selective mGluR5 antagonist, in development for the treatment of Fragile X Syndrome. The single ascending dose study is designed to evaluate the safety, tolerability and pharmacokinetics of STX107 in healthy volunteers. Fragile X Syndrome is the most common inherited form of mental impairment and the most common known cause of autism.
› Verified 8 days ago
Ali Hussain, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1144 N Road St, Elizabeth City, NC 27909 Phone: 703-776-3291 | |
Amandeep Singh, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1144 N Road St, Elizabeth City, NC 27909 Phone: 252-335-0531 | |
Karl Brandspigel, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 206 Hastings Ln, Elizabeth City, NC 27909 Phone: 252-335-1083 Fax: 252-335-4030 | |
Dr. Jasvinder Pal Singh, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1507 N Road St, Suite 1, Elizabeth City, NC 27909 Phone: 252-338-6167 Fax: 252-334-1755 | |
Ravi Ramsamooj, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 206 Hastings Ln, Elizabeth City, NC 27909 Phone: 252-335-1083 Fax: 252-335-4030 | |
Dr. Felicia Chang, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1507 N Road St Ste 2, Sentara Internal Medicine, Elizabeth City, NC 27909 Phone: 336-460-4306 | |
Dr. Steven P Manuli, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 104 Mill End Ct, Elizabeth City, NC 27909 Phone: 252-338-5183 Fax: 252-338-5669 |